OP12.11
Prediction of cervical changes and premature birth by cervical image pattern analysis using real-time tissue elastography
R. Nagai
Kochi Health Sciences Centre, Kochi-City, Kochi, Japan Objectives: To assess whether the symptom of premature birth can be predicted from cervical ultrasound image pattern by using Real-time Tissue Elastography. Methods: This was single facility prospective observational study including 187 pregnant women and 686 of the measurement data in pregnant women after 18 weeks in our hospital. Real-time Tissue Elastography (RTE) is a technique based on strain imaging, which uses external tissue compression and generates images of the resulting tissue strain, in the present study using the ultrasound equipment that RTE is installed (Hitachi Aloka Medical, Arietta70). Underwent ultrasound examination to pregnant women when measuring the cervix length as an evaluation of urgent premature birth, was evaluated by measuring the cervical imaging by RTE. Results: Of the 187 pregnant women and 18 high risk threatened premature birth (including pregnant women with cervix length less than 25 mm and pregnant women with history of cervical insufficiency in less than 24 weeks) were analysed. There were two cases of premature birth and one case requiring cervical cerclage of 18 cases, and in both cases cervical mosaic pattern and cervical linear pattern were observed. There were no cases showing cervical mosaic pattern in 15 pregnant women who did not become premature birth, and only 5 cases showed a cervical linear pattern. Conclusions: We estimate that earlier cervical ripening for delivery represents the cervical mosaic pattern and that the tissue distortions before and after the cervical canal represent a cervical linear pattern. In cases of premature birth, the cervical pattern by RTE may help diagnosis in pregnant women who cannot be diagnosed by cervical tract shortening or preterm birth history. Objectives: Small-for-gestational-age (SGA) fetuses are at higher risk of intrapartum fetal compromise requiring operative delivery. We aimed to develop and validate a predictive model for the risk of operative delivery due to fetal compromise in SGA fetuses at term. Methods: A single-centre cohort study of SGA [estimated fetal weight (EFW) <10th centile using INTERGROWTH-21 charts] singleton pregnancies at term. Major structural anomalies, aneuploidy, genetic syndromes, missing outcomes or antepartum stillbirth were excluded. Variables included known risk factors for operative delivery due to fetal compromise: maternal characteristics, EFW, abdominal circumference (AC), fetal Dopplers, gestational age at ultrasound, induction of labour and intrapartum risk factors (meconium, augmentation using oxytocin, epidural, pyrexia, hemorrhage). Logistic regression, ROC curve analysis, and Hosmer-Lemeshow tests were used to analyse the data. Validation of the models was performed internally with bootstrapped datasets. Results: 1014 pregnancies were included;17.9% had operative delivery. The antenatal model (AUC 0.68; 95%CI: 0.64,0.71) using only antenatal risk factors included parity, AC centile and cerebroplacental ratio (CPR). The combined model (AUC of 0.76; 95%CI 0.72,0.80) using both antenatal and intrapartum risk factors included AC centile (OR 0.96; 95%CI: 0.94,0.99), CPR MOM (OR 0.46; 95%CI: 0.24,0.89), parity (OR 0.27; 95%CI: 0.17,0.40), induction of labour (OR 1.62; 95%CI: 1.12,2.35), augmentation using oxytocin (OR 2.13; 95%CI: 1.45,3.11) and epidural (OR 2.81; 1.97,4.00). The results indicate that the model has good precision and according to Hosmer-Lemeshow test has good fit (p = 0.67).
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Conclusions: The prediction model shows good precision and calibration for assessing the risk of operative delivery for presumed fetal compromise in suspected SGA fetuses, and can be used for counselling women about their individual risk. Objectives: Fetal growth is directly related to maternal nutrient availability and the placenta's ability to transport these nutrients from maternal circulation to the fetus. We aimed to evaluate placental nutrient transport in small-for-gestational age (SGA) and fetal growth restricted (FGR) newborns. Methods: A nested case-control study including singleton pregnancies delivering at term classified as normally grown newborns (n=18) and small fetuses subclassified into SGA (if birthweight 3rd-9th centile normal fetoplacental Doppler, n=18) and FGR (if birthweight <3th centile and/or cerebroplacental ratio <5th centile and/or uterine artery mean pulsatility index>95th centile, n=18). RNA expression levels of GLUT1 (glucose transporter), SNAT1 (System A amino acids transporter), ABCA1 (cholesterol transporter) and FABP1 (fatty acids transporter) were analysed in placental samples collected at delivery. Results: While SNAT-1 expression was similar among groups, placental expression of GLUT1 was significantly reduced in both SGA and FGR cases (controls 1. Objectives: To assess the predictive capacity of maternal levels of angiogenic and antiangiogenic factors measured at 37 gestational weeks in identifying small-for-gestational age (SGA) neonates and adverse perinatal outcome (APO) in low-risk population. Methods: A prospective cohort of low-risk singleton pregnancies scanned at 37 weeks' was constructed. At inclusion, biometry for estimated fetal weight (EFW), fetoplacental Doppler evaluation, including uterine artery pulsatility index (UtA-PI), cerebroplacental ratio (CPR), umbilical vein blood flow (UVBF) normalised by EFW, and maternal circulating placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) were measured. SGA was defined as customised birthweight (BW) <10th centile and classified as FGR if <3rd centile, according to local standards. APO was considered
